​3rd Annual $50K AI Pre-Seed Pitch Day!

​New York City's top pre-seed AI startups will take the stage to pitch their startups to a roomful of investors

​The grand prize: a $50,000 investment from Flybridge Capital's Next Wave NYC fund!

​Each startup will pitch their story and demo their products live on stage. The showcase will be followed by a reception with drinks, light bites and good conversation.

​Apply to pitch

​If you're a pre-seed startup founder interested in applying to pitch - submit your application on the lynxcollective.com site. Each submission will be considered and reviewed by real VCs and regardless of selection, we'll provide feedback via Lynx Collective's Beacon tool. Deadline = June 12

​IMPORTANT NOTE: Submissions will be considered on a rolling basis, once 8 finalist are selected to compete we will close applications - so apply early!

​Investors: Want to attend?
Request a ticket on this page, space is limited so request your spot asap.

​*The $50k prize of an investment is subject to reason & light due diligence.

​About Next Wave NYC
Next Wave NYC is a pre-seed venture fund run by some of the best and brightest founders and operators from the last decade of the New York City startup scene - including founders/leaders of Anthropic, Brex, Casper, Chief, Classpass, Fizz, Foursquare, Lovable, NVIDIA, OpenAI, Snowflake, Squire & WeWork - primed to back the next generation of world-changing founders from this city.

​Our investment areas currently include Native AI applications, Agentic AI for the enterprise, and developer platforms for AI builders. Next Wave NYC is wholly backed by Flybridge Capital.

​Brought to you by Lynx Collective
Lynx Collective connects and supports the NYC startup ecosystem through curated events and a weekly newsletter, founded by longtime startup veterans Andrew Chang (investor, advisor, board member) and Dorothy Chang (investor at NextWave NYC & Flybridge).

​With many thanks to our sponsor:
Fenwick is a leading law firm, purpose-built to guide visionary tech and life sciences companies and their investors through every stage of growth, from startups securing their first round of funding to publicly traded global conglomerates. Consistently ranked a Chambers first-tier firm known for empowering industry innovators to redefine the boundaries of what’s possible.